IMMUNOLOGICAL MECHANISMS OF RESISTANCE TO CDK4/CDK6 INHIBITORS IN BREAST CANCER

被引：1
|
作者：
Petroni, Giulia [1 ]
Gouin, Kenneth [2 ]
Martinez, Aitziber Buque [1 ]
Knott, Simon [2 ]
Formenti, Silvia [1 ]
Galluzzi, Lorenzo [1 ,3 ]
机构：
[1] Weill Cornell Med Coll, Brooklyn, NY USA
[2] Cedars Sinai, Los Angeles, CA USA
[3] Weill Cornell Med, New York, NY USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.733
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
733
引用
收藏
页码：A763 / A763
页数：1
相关论文
共 50 条
  • [31] The Evolving Pathways of the Efficacy of and Resistance to CDK4/6 Inhibitors in Breast Cancer
    Gomes, Ines
    Abreu, Catarina
    Costa, Luis
    Casimiro, Sandra
    CANCERS, 2023, 15 (19)
  • [32] Mechanisms of resistance to CDK4/6 inhibition in ER plus breast cancer
    Lee, N. V.
    Eisele, K. J.
    Chionis, J.
    Yuan, J.
    Zhu, Z.
    Liu, C.
    Li, D.
    Olson, P. A.
    Fantin, V.
    Arndt, K. T.
    Shields, D. J.
    VanArsdale, T. L.
    CANCER RESEARCH, 2016, 76
  • [33] Unravelling mechanisms of resistance to CDK4/6 inhibitors using triple negative breast cancer (TNBC)
    Asghar, U.
    Barr, A.
    Cutts, R.
    Beaney, M.
    Sampath, D.
    Giltnane, J.
    Lacap, J. Arca
    Herrera-Abreu, M.
    Bakal, C.
    Turner, N.
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] CDK4 and CDK6 kinases: From basic science to cancer therapy
    Fassl, Anne
    Geng, Yan
    Sicinski, Piotr
    SCIENCE, 2022, 375 (6577) : 158 - +
  • [35] Development of personalized medicine for breast cancer based on elucidation of resistance mechanisms to CDK4/6 inhibitors
    Kobayashi, Yoshie
    Motoi, Yusuke
    Fujimoto, Mutsumi
    Shigematsu, Hideo
    CANCER RESEARCH, 2023, 83 (05)
  • [36] Improving Breast Cancer Therapy With CDK4/6 Inhibitors
    Jaganathan, Hamsa
    Overstreet, Karen
    Reed, Elizabeth
    CLINICAL BREAST CANCER, 2014, 14 (06) : 379 - 380
  • [37] Predicting Response to CDK4/6 Inhibitors in Breast Cancer
    Schultz, Emily
    Hamilton, Deanna
    Wang, Jianxin
    Witkiewicz, Agnieszka
    LABORATORY INVESTIGATION, 2023, 103 (03) : S208 - S208
  • [38] CDK4/6 inhibitors in breast cancer: spotting the difference
    Perez-Garcia, Jose Manuel
    Cortes, Javier
    Llombart-Cussac, Antonio
    NATURE MEDICINE, 2021, 27 (11) : 1868 - 1869
  • [39] PALBOCICLIB Cyclin CDK4/CDK6 Inhibitor Oncolytic
    Haddley, K.
    DRUGS OF THE FUTURE, 2013, 38 (11) : 745 - 755
  • [40] CDK4/6 Inhibitors in the Treatment of Metastatic Breast Cancer
    Ettl, Johannes
    Huober, Jens
    Lueftner, Diana
    Marme, Frederik
    Wuerstlein, Rachel
    BREAST CARE, 2017, 12 (02) : 118 - 120
12345